[
  {
    "ts": "2025-11-13T14:40:03+00:00",
    "headline": "Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finance.yahoo.com/news/why-ge-healthcare-technologies-gehc-144003296.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e4c80f50-bd72-3e84-854c-18e96a9c3f2c",
      "content": {
        "id": "e4c80f50-bd72-3e84-854c-18e96a9c3f2c",
        "contentType": "STORY",
        "title": "Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term",
        "description": "",
        "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
        "pubDate": "2025-11-13T14:40:03Z",
        "displayTime": "2025-11-13T14:40:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
          "originalWidth": 900,
          "originalHeight": 588,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5gRNxwBpnI6i3Dv1dI7wfg--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 900,
              "height": 588,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3D4iv84vYyo09.dnUK_wsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-ge-healthcare-technologies-gehc-144003296.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-ge-healthcare-technologies-gehc-144003296.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-13T21:01:00+00:00",
    "headline": "Amneal Receives U.S. FDA Approval for Iohexol Injection",
    "summary": "First-to-market complex injectable with expected launch in Q1 2026BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque® (iohexol) injection. Amneal expects to launch the product in the first quarter of 2026. Iohexol is a radiographic contrast agent",
    "url": "https://finance.yahoo.com/news/amneal-receives-u-fda-approval-210100118.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c032eb52-1e54-39f1-9b59-0fd0b9fd5245",
      "content": {
        "id": "c032eb52-1e54-39f1-9b59-0fd0b9fd5245",
        "contentType": "STORY",
        "title": "Amneal Receives U.S. FDA Approval for Iohexol Injection",
        "description": "",
        "summary": "First-to-market complex injectable with expected launch in Q1 2026BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque® (iohexol) injection. Amneal expects to launch the product in the first quarter of 2026. Iohexol is a radiographic contrast agent",
        "pubDate": "2025-11-13T21:01:00Z",
        "displayTime": "2025-11-13T21:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/4ef791be3a2f9474e065b2685657b811",
          "originalWidth": 1176,
          "originalHeight": 523,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IKyNav9GQ9ogucPWSYDjpA--~B/aD01MjM7dz0xMTc2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/4ef791be3a2f9474e065b2685657b811.cf.webp",
              "width": 1176,
              "height": 523,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Vhb7d4stZ8zkWXJ.vAyibQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/4ef791be3a2f9474e065b2685657b811.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amneal-receives-u-fda-approval-210100118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amneal-receives-u-fda-approval-210100118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMRX"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]